Helius Medical Technologies, Inc.
HSDT
$6.27
$0.0450.72%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.16% | -73.05% | |||
| Total Other Revenue | -9.09% | 0.00% | |||
| Total Revenue | -12.24% | -67.76% | |||
| Cost of Revenue | -20.66% | -21.43% | |||
| Gross Profit | 26.39% | -3,500.00% | |||
| SG&A Expenses | -18.27% | 37.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.12% | 24.58% | |||
| Operating Income | 17.18% | -29.10% | |||
| Income Before Tax | -156.20% | 2.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -156.20% | 2.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -156.20% | 2.29% | |||
| EBIT | 17.18% | -29.10% | |||
| EBITDA | 34.22% | -29.34% | |||
| EPS Basic | 79.07% | -- | |||
| Normalized Basic EPS | 79.07% | -- | |||
| EPS Diluted | 79.16% | -- | |||
| Normalized Diluted EPS | 79.07% | -- | |||
| Average Basic Shares Outstanding | 1,120.79% | -- | |||
| Average Diluted Shares Outstanding | 1,120.79% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||